It is estimated that erectile dysfunction (ED) affects more than 150 million people worldwide and this number is expected to double by the year 2025. Vascular component represents the most important etiological cause of erectile dysfunction. ED shares almost all risk factors, such as hypertension, diabetes mellitus, hyperlipidaemia and smoking, with arteriosclerosis. Moderate to severe ED is associated with a considerably increased risk for coronary heart disease (CHD). This review was conducted in May 2016, when the PubMed database was searched using the combination of the terms “erectile dysfunction” and “cardiovascular diseases”, “coronary artery diseases” and “risk factors”. In this review, we analyzed the published literature, regarding the predictive role of ED in CVD and the association of ED risk factors with CVD risk factors, aiming to draw particular attention on the role of sexual inquiry of all men to prevent or decrease major cardiovascular events. In conclusion, the early detection of ED can prevent major cardiovascular events with early management of cardiovascular risk and permits to include patients in a risk stratification group. Erectile function should be evaluated using questionnaires in all male patients to prevent and decrease the rates of major cardiovascular events.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. NIH Consensus Conference. Impotence. NIH development panel on impotence. JAMA. 1993;270(1):83-90.
2. Lue TF ed. Impotence and infertility. In: Vaughan ED Jr Perlmutter AP eds. Atlas of Clinical Urology. Vol 1. Philadelphia Pa: Current Medicine Inc; 1999.
3. Feldman HA Goldstein I Hatzichristou D Krane RJ McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachussets Male Aging study. J Urol. 1994;151:54-61.
4. Seftel AD Sun P Swindle R. The prevalence of hypertension hyperlipidemia diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004;171:2341-2345.
5. Solomon H Man JW Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251-253.
6. Feldman HA Johannes CB Derby CA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30:328-338.
7. Fung MM Bettencourt R Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study. J Am Coll Cardiol. 2004;43:1405-1411.
8. Ronald WL Kersten S Meyer F et al. Epidemiology/risk factors of sexual dysfunction. J SexMed. 2004;1(1):35-39.
9. Mons P Van Deyk K Marquette K De Bleser L Budts W De Geets S. Sexual Functioning and congenital heart disease: Something to worry about? Int J Cardiol. 2007;121(1):30-35.
10. Montorsi P Montorsi F Schulman CC. Is erectile dysfunction the ‘tip of the iceberg’ of a systemic vascular disorder? EurUrol. 2003;44:352-354.
11. McGovern PG Pancow JS Shahar E et al. Recent trends in acute coronary heart disease:mortality morbidity medical care and risk factors. N Engl J Med. 1996;334(14):884-890.
12. Thompson IM Tangen CM Goodman PJ Probstfield JL Moinpour CM Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294:2996-3002.
13. Schouten BW Bohnen AM Bosch JL et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen study. Int J Impot Res. 2008;20:92-99.
14. Ponholzer A Temml C Obermayr R Wehrberger C Madersbacher S. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol. 2005;48:512-518.
15. Feldman HA Goldstein I Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1999;151:54-61.
16. Virag R Bouilly P Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 1985;1:181-184.
17. Martin-Morales A Sanchez-Cruz JJ Saenz de Tejada I et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166:569-575.
18. Blanker MH Bohnen AM Groeneveld FP et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community based study. J Am Geriatr Soc. 2001;49(4):436-442.
19. Solomon H Man JW Jackson G. Erectile dysfunction and the cardiovascular patient: endotelial dysfunction is the common denominator. Heart. 2003;89:251-253.
20. Mass R Schwedhelem E Albseier J et al. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med. 2002;7:213-225.
21. Greenland P LaBree L Azen SP et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
22. Detrano RC Doherty TM Davies MJ et al. Predicting coronary events with coronary calcium: pathophysiologic and clinical problems. Curr Probl Cardiol. 2000;25:374-402.
23. Schmermund A Möhlenkamp S Erbel R. Coronary artery calcium and its relationship to coronary artery disease. Cardiol Clin. 2003;21(4):521ü534.
24. Selvin E Burnett AL Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151-7.
25. Persu C Cauni V Gutue S Albu ES Jinga V Geavlete P. Diagnosis and treatment of erectile dysfunction — a practical update. J Med Life. 2009;2(4):394-400.
26. Aytac IA Araujo AB Johannes CB Kleinman KP McKinlay JB. Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachussetts male aging study. Soc Sci Med. 2000;51(5):771-778.
27. Meller SM Stilp E Walker CN Mena-Hurtado C. The link between vasculogenic erectile dysfunction coronary artery disease and peripheral artery disease: role of metabolic factors and endovascular therapy. J Invasive Cardiol. 2013;25(6):313-319.
28. Greenstein A Chen J Miller H Matzkin H Villa Y Braf Z. Does severity of ischemiccoronary disease correlate with erectile function? Int J Impot Res. 1997;9(3):123-126.
29. Gupta BP Clifton MM Prokop L Nehra A Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: A systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797-1803.
30. Shamloul R Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153-165.
31. Lue TF. Erectile dysfunction. New Engl J Med. 2000;342(24):1802-1813.
32. Billups KL Bank AJ Padma-Nathan H et al. Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med. 2005;2:40-50.
33. Lakka HM Laaksonen DE Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
34. Van Gaal LF Rissanen AM Scheen AJ et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet. 2005;365:1389-1397.
35. Selvin E Burnett AL Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151-157.
36. Kubin M Wagner G Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res. 2003;15(1):63-71.
37. Akdemir R Karakurt O Orcan S et al. Comparison between primary angioplasty and thrombolytic therapy on erectile dysfunction after acute ST elevation myocardial infarction. Asian J Androl. 2012;14(5):784-787.
38. Montorsi P Ravagnani PM Galli S et al. Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol. 2006;50:721-731.
39. Montorsi F Briganti A Salonia A et al. Erectile dysfunction prevalence time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003;44(3):360-364; discussion 364-365.
40. Hodges LD Kirby M Solanki J O'Donnell J Brodie DA. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract. 2007;61(12):2019-2025.
41. Gazzaruso C Giordanetti S De Amici E. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110(1):22-26.
42. Solomon H Man JW Wierzbicki AS Jackson G. Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol. 2003;91(2):230-231.
43. Vlachopoulos C Rokkas K Ioakeimidis N. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol. 2005;48(6):996-1003.
44. Montorsi P Ravagnani PM Galli S. Association between erectile dysfunction and coronary artery disease: role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J. 2006;27(22):2632-2639.
45. Araujo AB Travison TG Ganz P. Erectile dysfunction and mortality. J Sex Med. 2009;6(9):2445-2454.
46. Inman BA Sauver JL Jacobson DJ. A population-based longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108-113.
47. Chew KK Finn J Stuckey B. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med. 2010;7(1):192-202.
48. Hall SA Shackelton R Rosen RC Araujo AB. Sexual activity erectile dysfunction and incident cardiovascular events. Am J Cardiol. 2010;105(2):192-197.
49. Polonsky TS Taillon LA Sheth H et al. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009;207(2):440-444.
50. Nehra A Jackson G Miner M et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-78.